sulbactam has been researched along with Renal Insufficiency in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Isaacs, R; Mamikonyan, G; O'Donnell, J; Preston, RA; Stone, E | 1 |
Ikawa, K; Matsumoto, K; Morikawa, N; Takeda, Y; Watanabe, E; Yokoyama, Y | 1 |
Acikgoz, ZC; Guner, R; Guven, T; Izdes, S; Kocak Tufan, Z; Tasyaran, MA; Yilmaz, GR | 1 |
Costa, SF; Grinbaum, RS; Levin, AS; Oliveira, MS; Prado, GV | 1 |
4 other study(ies) available for sulbactam and Renal Insufficiency
Article | Year |
---|---|
Pharmacokinetics, Safety, and Tolerability of Intravenous Durlobactam and Sulbactam in Subjects with Renal Impairment and Healthy Matched Control Subjects.
Topics: Acinetobacter baumannii; Administration, Intravenous; Aged; Area Under Curve; Azabicyclo Compounds; Female; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Renal Insufficiency; Sulbactam | 2019 |
Population pharmacokinetic-pharmacodynamic target attainment analysis of sulbactam in patients with impaired renal function: dosing considerations for Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Models, Biological; Renal Insufficiency; Sulbactam | 2015 |
Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia, Ventilator-Associated; Renal Insufficiency; Retrospective Studies; Sulbactam; Treatment Outcome | 2015 |
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ampicillin; APACHE; beta-Lactam Resistance; Bronchoalveolar Lavage Fluid; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Hospitals, Teaching; Humans; Infant; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymyxins; Prognosis; Renal Insufficiency; Retrospective Studies; Risk Factors; Shock, Septic; Sulbactam; Time Factors; Treatment Outcome | 2008 |